U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


International Stabilization Force for Gaza Nears Deployment as U.S.-Led Planning Advances
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Bolivia Orders Pre-Trial Detention of Former President Luis Arce Over Embezzlement Probe
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
U.S. Lifts Sanctions on Brazilian Supreme Court Justice Amid Shift in Brazil Relations
Indonesia–U.S. Tariff Talks Near Completion as Both Sides Push for Year-End Deal
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
US Charges Two Men in Alleged Nvidia Chip Smuggling Scheme to China
Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns
Trump Administration Fuel-Efficiency Rollback Could Raise Long-Term Costs for U.S. Drivers 



